KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Taxes (2016 - 2025)

Globus Medical's Change in Taxes history spans 15 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Change in Taxes rose 183.34% year-over-year to $7.1 million; the TTM value through Dec 2025 reached -$50.9 million, down 280.14%, while the annual FY2025 figure was -$50.9 million, 280.14% down from the prior year.
  • Change in Taxes reached $7.1 million in Q4 2025 per GMED's latest filing, up from -$19.3 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $40.5 million in Q1 2024 to a low of -$58.2 million in Q2 2025.
  • Average Change in Taxes over 5 years is -$3.1 million, with a median of -$741500.0 recorded in 2021.
  • The largest YoY upside for Change in Taxes was 753.41% in 2021 against a maximum downside of 697.74% in 2021.
  • A 5-year view of Change in Taxes shows it stood at $15.0 million in 2021, then plummeted by 114.48% to -$2.2 million in 2022, then tumbled by 533.62% to -$13.8 million in 2023, then surged by 38.37% to -$8.5 million in 2024, then surged by 183.34% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Change in Taxes are $7.1 million (Q4 2025), -$19.3 million (Q3 2025), and -$58.2 million (Q2 2025).